Literature DB >> 1737852

Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.

C A Felix1, M M Nau, T Takahashi, T Mitsudomi, I Chiba, D G Poplack, G H Reaman, D E Cole, J J Letterio, J Whang-Peng.   

Abstract

The p53 gene was examined in primary lymphoblasts of 25 pediatric patients with acute lymphoblastic leukemia by the RNase protection assay and by single strand conformation polymorphism analysis in 23 of 25 cases. p53 mutations were found to occur, but at a low frequency (4 of 25). While all four mutations were identified by single strand conformation polymorphism, the comparative sensitivity of RNase protection was 50% (2 of 4). Heterozygosity was retained at mutated codons in 3 of 4 cases. One pedigree was consistent with the Li-Fraumeni syndrome, and bone marrow from both diagnosis and remission indicated a germline G to T transversion at codon 272 (valine to leucine). Although members of another family were affected with leukemia, a 2-bp deletion in exon 6 was nonhereditary. The other two nonhereditary p53 mutations included a T to G transversion at codon 270 (phenylalanine to cysteine) and a G to C transversion at codon 248 (arginine to proline). These data support the role of both hereditary and acquired p53 mutations in the pathogenesis and/or progression of some cases of childhood acute lymphoblastic leukemia.

Entities:  

Mesh:

Year:  1992        PMID: 1737852      PMCID: PMC442897          DOI: 10.1172/JCI115630

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicine administration.

Authors:  J H TJIO; J WHANG
Journal:  Stain Technol       Date:  1962-01

2.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

Review 3.  Chromosome translocations in human cancer.

Authors:  J R Testa
Journal:  Cell Growth Differ       Date:  1990-02

4.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

5.  Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

Authors:  J M Varley; W J Brammar; D P Lane; J E Swallow; C Dolan; R A Walker
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

6.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Cancer. Gene losses in human tumours.

Authors:  B Ponder
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

9.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

View more
  12 in total

1.  Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.

Authors:  C A Felix; D D'Amico; T Mitsudomi; M M Nau; F P Li; J F Fraumeni; D E Cole; J McCalla; G H Reaman; J Whang-Peng
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Absence of germline and somatic p53 alterations in children with sporadic brain tumors.

Authors:  C Portwine; S Chilton-MacNeill; C Brown; E Sexsmith; J McLaughlin; D Malkin
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

Review 3.  Tumors associated with p53 germline mutations: a synopsis of 91 families.

Authors:  P Kleihues; B Schäuble; A zur Hausen; J Estève; H Ohgaki
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

Review 4.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma.

Authors:  K Iyota; K Takeda; F Matsuzuka; T Okabayashi; S Morita; K Kuma; K Hashimoto
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

8.  Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.

Authors:  A Y Matsushima; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

9.  Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

Authors:  T Frebourg; N Barbier; Y X Yan; J E Garber; M Dreyfus; J Fraumeni; F P Li; S H Friend
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

Review 10.  Poor-risk high-grade gliomas in three survivors of childhood acute lymphoblastic leukaemia--an overview of causative factors and possible therapeutic options.

Authors:  Ewa Bien; Teresa Stachowicz-Stencel; Magdalena Szalewska; Malgorzata Krawczyk; Anna Synakiewicz; Miroslawa Dubaniewicz-Wybieralska; Piotr Zielinski; Elzbieta Adamkiewicz-Drozynska; Anna Balcerska
Journal:  Childs Nerv Syst       Date:  2009-03-20       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.